Reducing risk in AI and machine learning-based medical technology

Along with the benefits come new risks and regulatory challenges meaning doctors now have to consider how best to reduce risk when it comes to medical technology. From spotting malignant tumours to reading CT scans and mammograms, Artificial Intelligence and Machine Learning-based technology is faster and more accurate than traditional devices – or even the best doctors. In a new article, Algorithms on regulatory lockdown in medicine, recently published in Science, researchers look at the new challenges facing regulators as they navigate the unfamiliar pathways of Artificial Intelligence and Machine Learning. In the paper, the researchers consider the questions: what new risks do we face as Artificial Intelligence and Machine Learning (AI/ML) devices are developed and implemented? How should they be managed?